Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
18 hedge funds and large institutions have $8.25M invested in Biocept, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
941% more capital invested
Capital invested by funds: $793K → $8.25M (+$7.46M)
600% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 2
125% more funds holding
Funds holding: 8 → 18 (+10)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.51M |
| 2 |
BlackRock
New York
|
+$1.46M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$901K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$748K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$319K |
| 2 |
GCM
Goldman Capital Management
New York
|
-$238K |
| 3 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$12K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$1K |
BIOC Hedge Fund Activity: Q1 2017 in Review
18 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2017, worth a combined $8.25M — up 941% from $793K a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BIOC positions and 2 closed out — a net gain of 12 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.51M. The largest seller was Sabby Management, exiting entirely with an estimated $319K sold.
- 18 institutional investors held Biocept, Inc. (BIOC) as of Q1 2017, up from 8 in Q4 2016.
- Funds reported $8.25M of Biocept, Inc. stock for Q1 2017, up 941% quarter-over-quarter.
- 14 funds opened new Biocept, Inc. positions in Q1 2017 and 2 closed out, a net change of +12 holders.
- The largest Biocept, Inc. buyer in Q1 2017 was Susquehanna International Group, an estimated $1.51M added.
- The largest Biocept, Inc. seller in Q1 2017 was Sabby Management, an estimated $319K sold.
Based on aggregated 13F filings for Q1 2017.